These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 28972088)
1. NFAT1 Regulates Systemic Autoimmunity through the Modulation of a Dendritic Cell Property. Chae CS; Kim GC; Park ES; Lee CG; Verma R; Cho HL; Jun CD; Yoo YJ; Im SH J Immunol; 2017 Nov; 199(9):3051-3062. PubMed ID: 28972088 [TBL] [Abstract][Full Text] [Related]
2. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385 [TBL] [Abstract][Full Text] [Related]
3. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization. Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647 [TBL] [Abstract][Full Text] [Related]
4. NFAT1 transcription factor in dendritic cells is required to modulate T helper cell differentiation. Barboza BA; Fonseca BP; Viola JP Immunobiology; 2014 Sep; 219(9):704-12. PubMed ID: 24894426 [TBL] [Abstract][Full Text] [Related]
5. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041 [TBL] [Abstract][Full Text] [Related]
6. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation. Suryawanshi A; Manoharan I; Hong Y; Swafford D; Majumdar T; Taketo MM; Manicassamy B; Koni PA; Thangaraju M; Sun Z; Mellor AL; Munn DH; Manicassamy S J Immunol; 2015 Apr; 194(7):3295-304. PubMed ID: 25710911 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines. Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702 [TBL] [Abstract][Full Text] [Related]
9. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. Jung MY; Son MH; Kim SH; Cho D; Kim TS J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364 [TBL] [Abstract][Full Text] [Related]
10. STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis. Prado C; Ugalde V; González H; Figueroa A; López E; Lladser A; Pacheco R J Immunol Res; 2019; 2019():1982570. PubMed ID: 31355296 [TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170 [TBL] [Abstract][Full Text] [Related]
12. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18. Im SH; Barchan D; Maiti PK; Raveh L; Souroujon MC; Fuchs S FASEB J; 2001 Oct; 15(12):2140-8. PubMed ID: 11641240 [TBL] [Abstract][Full Text] [Related]
13. NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms. Dietz L; Frommer F; Vogel AL; Vaeth M; Serfling E; Waisman A; Buttmann M; Berberich-Siebelt F Eur J Immunol; 2015 May; 45(5):1377-89. PubMed ID: 25630465 [TBL] [Abstract][Full Text] [Related]
14. Attenuated Streptococcus pneumoniae vaccine candidate SPY1 promotes dendritic cell activation and drives a Th1/Th17 response. Gao S; Zeng L; Zhang X; Wu Y; Cui J; Song Z; Sun X; Wang H; Yin Y; Xu W Immunol Lett; 2016 Nov; 179():47-55. PubMed ID: 27609353 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response. Wang J; Zheng S; Xin N; Dou C; Fu L; Zhang X; Chen J; Zhang Y; Geng D; Xiao C; Cui G; Shen X; Lu Y; Wang J; Dong R; Qiao Y; Zhang Y J Neuroimmune Pharmacol; 2013 Dec; 8(5):1287-302. PubMed ID: 24043548 [TBL] [Abstract][Full Text] [Related]
16. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis. Xiao BG; Duan RS; Zhu WH; Lu CZ Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165 [TBL] [Abstract][Full Text] [Related]
17. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells. Duan RS; Adikari SB; Huang YM; Link H; Xiao BG Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302 [TBL] [Abstract][Full Text] [Related]
18. Effect of Grilled Nux Vomica on Differential RNA Expression Profile of Gastrocnemius Muscle and Toll‑Like Receptor 4 (TLR-4)/Nuclear Factor kappa B (NF-κB) Signaling in Experimental Autoimmune Myasthenia Gravis Rats. Jiang XH; Chen Y; Ding YY; Qiu H; Zhou DY; Qiu CL Med Sci Monit; 2020 Feb; 26():e919150. PubMed ID: 32052794 [TBL] [Abstract][Full Text] [Related]
19. Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance. Baratin M; Foray C; Demaria O; Habbeddine M; Pollet E; Maurizio J; Verthuy C; Davanture S; Azukizawa H; Flores-Langarica A; Dalod M; Lawrence T Immunity; 2015 Apr; 42(4):627-39. PubMed ID: 25862089 [TBL] [Abstract][Full Text] [Related]